Literature DB >> 6515700

Clinical correlates of methylphenidate blood levels.

C T Gualtieri, R E Hicks, K Patrick, S R Schroeder, G R Breese.   

Abstract

The clinical correlates of methylphenidate blood levels in hyper-active children and normal adults were examined in five studies. Although occasional correlations between blood levels and neuroendocrine response were noted within subjects along the pharmacokinetic time profile of the drug, no significant associations were found between blood levels and clinical response in behavioral measures or laboratory tests of attention or activity. It is unlikely that routine methylphenidate blood level determinations will become a part of the routine clinical management of hyperactive children.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6515700     DOI: 10.1097/00007691-198412000-00001

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  11 in total

Review 1.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

2.  The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.

Authors:  Claus Stage; Gesche Jürgens; Louise Schow Guski; Ragnar Thomsen; Ditte Bjerre; Laura Ferrero-Miliani; Yassine Kamal Lyauk; Henrik Berg Rasmussen; Kim Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2017-02-24       Impact factor: 4.335

3.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 4.  Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.

Authors:  James C Ermer; Ben A Adeyi; Michael L Pucci
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

Review 5.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

6.  Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Authors:  John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers.

Authors:  T Aoyama; H Kotaki; T Sasaki; Y Sawada; Y Honda; T Iga
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 8.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 9.  Drug therapy for adults with attention-deficit hyperactivity disorder.

Authors:  Timothy E Wilens
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  [Pharmacological treatment in adults with attention deficit hyperactivity disorder].

Authors:  J Frölich; G Lehmkuhl
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.